VERTEX PHARMACEUTICALS INC / MA 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Dec 16, 2014
Insider Transaction Report
Form 4
Connolly Thomas
SVP, Human Resources
Transactions
- Sale
Common Stock
2014-12-12$119.73/sh−300$35,919→ 34,595 total - Sale
Common Stock
2014-12-12$120.50/sh−220$26,510→ 34,375 total
Holdings
- 150(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $119.73 (range $119.31 to $120.25).
- [F3]Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $120.50 (range $120.45 to $120.57).